Navidea to license Alseres Parkinson's disease imaging agent
11:41 EDT 1 Aug 2012 | Medical Business Review
Navidea Biopharmaceuticals has entered into an agreement to license Alseres Pharmaceuticals' Iodine-123 radiolabeled imaging agent, [123I]-E-IACFT Injection (CFT).
Original Article: Navidea to license Alseres Parkinson's disease imaging agent
More From BioPortfolio on "Navidea to license Alseres Parkinson's disease imaging agent"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
